研究
研究
新しい技術が企業や産業、ビジネスモデルをどう変えるのか。そして、そのまわりに生まれるエコシステムを健全に保つには何が必要なのかを研究しています。
01
研究テーマ
- 01
人工知能(AI)
生成AIやエージェントが、組織のかたちや価値の生み方をどう変えるのか。AIが誰にでも使えるようになったとき、何が強みとして残るのかを考えています。
- 02
デジタルイノベーション
企業が技術・組織・エコシステムの変化をどう組み立て、技術的な可能性を現場の現実に変えていくのか。
- 03
ビジネスモデル
データや業務知識、顧客との関係をどう組み合わせれば、長く続く強みになるのか。
- 04
デジタルヘルス
ソフトウェアによる医療のイノベーションが、規制と市場のなかでどう育っていくのか。
現在の研究
生成AI補完財企業の生存と成長
基盤モデルの上にプロダクトをつくること自体は、かつてないほど簡単になりました。それでも、長く価値を生み出せる企業はごく一部です。簡単に置き換えられてしまう「LLMラッパー」で終わらず成長していくには、どのようなビジネスモデルの組み合わせが効いているのかを研究しています。
今後の研究
生成AIエコシステムにおけるイノベーション・ガバナンス
生成AIは、社会全体で使われる共通の基盤になりつつあります。少数の基盤モデル事業者を中心に、そのAPIでサービスをつくる企業、導入する組織、実際に使う人々、そしてルールをつくる側までを含む、ひとつのエコシステムができあがっています。
誰でも参入しやすい環境は、たくさんの新しいサービスを生み出しました。一方で、特定の事業者への強い依存や、力の偏りも生まれています。これからは、その間に立つ企業が依存とどう付き合い、価値を生み出し続けていけるのか。そして、エコシステムを多様で公正、安全なものに保つにはどのようなガバナンスが必要なのかを明らかにしていきたいと考えています。
02
主な論文
- [3]
Jiakan Yu, Jiajie Zhang, Shuto Miyashita, Shintaro Sengoku (2026). Innovation trajectory of Software as a Medical Device: Evidence from the US FDA-approved products. DIGITAL HEALTH, 12, 20552076261464265.
査読ありDOI: 10.1177/20552076261464265
› 要旨
要旨は英語原文のまま掲載しています。
Background. Digital health innovation is reshaping healthcare, with Software as a Medical Device (SaMD) as a critical frontier. However, little is known about how enterprises evolve portfolios within this regulated market.
Objectives. This study uses enterprise-level SaMD product portfolio data to characterize innovation trajectories in SaMD development and assess heterogeneity in these trajectories across enterprise characteristics.
Methods. We identify 578 FDA-approved products from 289 enterprises (2012–2022) using the OpenFDA database. A multi-state model tracked innovation dynamics across 4 states: (1) one initial approval, (2) multiple approvals in identical area, (3) expansion into 2 areas, and (4) diversification into 3 or more areas. We apply Kaplan–Meier survival analysis with log-rank tests, competing-risk cumulative incidence analysis, and Cox proportional hazards regression to examine how enterprise size and industry classification influenced portfolio expansion, with right-censoring at the observation end date.
Results. The analysis reveals stagnating innovation trajectories. 67% (n=193) of enterprises made only a single FDA submission. Kaplan–Meier estimation yielded a median time to first portfolio expansion of 8.41 years over a 10-year observation window, with large enterprises transitioning significantly faster than micro enterprises (p<0.001). Neither industry nor entry timing showed significant differences. Cumulative incidence functions show that the five-year cumulative incidence of focused expansion (33.6%) was five times that of diversification (6.4%). Cox proportional hazards regression confirms enterprise size as the dominant predictor (micro vs. large HR=0.19, p<0.005). Software enterprises show a significantly higher expansion hazard (HR=2.15, p=0.04), while other industry types showed no significant effect.
Conclusions. Innovation of SaMD follows structurally constrained trajectories. We propose that this is caused by resource barrier that hinders smaller enterprises. Overcoming this barrier requires innovation systems that facilitate integration of complementary assets. Sustainable innovation depends on shifting from isolated product development to coordinated, multi-domain ecosystems.
- [2]
Jiakan Yu, Jiajie Zhang, Shintaro Sengoku (2023). Innovation Process and Industrial System of US Food and Drug Administration–Approved Software as a Medical Device: Review and Content Analysis. Journal of Medical Internet Research, 25, e47505.
› 要旨
要旨は英語原文のまま掲載しています。
Background. There has been a surge in academic and business interest in software as a medical device (SaMD). SaMD enables medical professionals to streamline existing medical practices and make innovative medical processes such as digital therapeutics a reality. Furthermore, SaMD is a billion-dollar market. However, SaMD is not clearly understood as a technological change and emerging industry.
Objective. This study aims to review the landscape of SaMD in response to increasing interest in SaMD within health systems and regulation. The objectives of the study are to (1) clarify the innovation process of SaMD, (2) identify the prevailing typology of such innovation, and (3) elucidate the underlying mechanisms driving the SaMD innovation process.
Methods. We collected product information on 581 US Food and Drug Administration–approved SaMDs from the OpenFDA website and 268 company profiles of the corresponding manufacturers from Crunchbase, Bloomberg, PichBook.com, and other company websites. In addition to assessing the metadata of SaMD, we used correspondence and business process analysis to assess the distribution of intended use and how SaMDs interact with other devices in the medical process.
Results. The current SaMD industry is highly concentrated in medical image processing and radiological analysis. Incumbents in the medical device industry currently lead the market and focus on incremental innovation, whereas new entrants, particularly startups, produce more disruptive innovation. We found that hardware medical device functions as a complementary asset for SaMD, whereas how SaMD interacts with the complementary asset differs according to its intended use. Based on these findings, we propose a regime map that illustrates the SaMD innovation process.
Conclusions. SaMD, as an industry, is nascent and dominated by incremental innovation. The innovation process of the present SaMD industry is shaped by data accessibility, which is key to building disruptive innovation.
- [1]
Itsuki Kageyama, Nobuki Hashiguchi, Jianfei Cao, Makoto Niwa, Yeongjoo Lim, Masanori Tsutsumi, Jiakan Yu, Shintaro Sengoku, Soichiro Okamoto, Seiji Hashimoto, Kota Kodama (2022). Determination of Waste Management Workers’ Physical and Psychological Load: A Cross-Sectional Study Using Biometric Data. International Journal of Environmental Research and Public Health, 19(23), 15964.
査読ありDOI: 10.3390/ijerph192315964
› 要旨
要旨は英語原文のまま掲載しています。
Waste management workers experience high stress and physical strain in their work environment, but very little empirical evidence supports effective health management practices for waste management workers. Hence, this study investigated the effects of worker characteristics and biometric indices on workers’ physical and psychological loads during waste-handling operations. A biometric measurement system was installed in an industrial waste management facility in Japan to understand the actual working conditions of 29 workers in the facility. It comprised sensing wear for data collection and biometric sensors to measure heart rate (HR) and physical activity (PA) based on electrocardiogram signals. Multiple regression analysis was performed to evaluate significant relationships between the parameters. Although stress level is indicated by the ratio of low frequency (LF) to high frequency (HF) or high LF power in HR, the results showed that compared with workers who did not handle waste, those who did had lower PA and body surface temperature, higher stress, and lower HR variability parameters associated with higher psychological load. There were no significant differences in HR, heart rate interval (RRI), and workload. The psychological load of workers dealing directly with waste was high, regardless of their PA, whereas others had a low psychological load even with high PA. These findings suggest the need to promote sustainable work relationships and a quantitative understanding of harsh working conditions to improve work quality and reduce health hazards.
03
学会発表
- 2026年Open Innovation Configurations for Software as a Medical Device Implementation: A Qualitative Systematic Review of Multi-Stakeholder Perspectives. InnoTech 2026 (ポスター発表)
- 2025年Innovation Trajectory of Software as a Medical Device Development: Evidence in the US FDA-Approved Products. ISPIM Osaka 2025 (口頭発表)
- 2023年3月Industrial System and Innovation Process of Software as Medical Device (SaMD). Jiakan Yu. 日本MOT学会 第14回年次研究発表会(2022年度), オンライン
- 2022年10月Innovation Process and Industrial Structure of Software as Medical Device (SaMD). Jiakan Yu. 研究・イノベーション学会 第37回年次学術大会(2022年), オンライン
- —Why the Declining Birthrate Has Accelerated Due to the Corona Crisis: An Analysis Based on SNS. Jiajie Zhang, Jiakan Yu. 計算社会科学会
04
受賞・招待講演
- 2024年11月招待講演: 第10回 DIA Medical Device Development Symposium. DIA Japan 主催
- 2023年3月受賞: Student Award(学生賞). 研究・イノベーション学会 第37回年次学術大会(2022年)
05
研究手法
パネルデータ分析 · 生存時間分析 · 潜在クラス分析 · 質的比較分析(QCA) · ネットワーク分析 · テキストマイニング・計量書誌学 · システマティック・レビュー · 半構造化インタビュー